Medicine Poster Session
The adverse effects of overeating and a sedentary life style are well documented (1). In rats, the single most effective way to prolong life is by significant and chronic under nutrition (without malnutrition)(2). Voluntary wheel-running, on the other hand, has a much more modest, but nonetheless, beneficial effect on longevity (3). Not surprisingly, there is an important public health campaign to promote weight loss and "get physical" (4). However, preoccupations with weight loss and excessive exercise are risk factors for anorexia nervosa (5) and the female athlete triad.
The female athlete triad is associated with disordered eating, amenorrhea, and osteoporosis (6). The American College of Sports Medicine emphasizes the need to recognize the triad in active females. It also emphasizes that when one component is present the physician should look for the other components (6). Various authors suggest that the initiating factor for the triad is disordered eating (7). An important type of eating disorder is anorexia nervosa, which has one of the highest mortality rates of any psychiatric disorder (8). Competitive female athletes are at increased risk for anorexia nervosa (e.g., 6,9) and numerous authors argue that excess physical activity is a risk factor for anorexia nervosa (5,9,10,11). This a complex disorder with multiple predisposing, precipitating and perpetuating factors (12). Animal modeling is one way to focus on specific aspects of the problem.
The most popular animal model of anorexia nervosa is the weight-loss syndrome produced by freely induced wheel-running in rats maintained on a moderate food deprivation schedule (see 13,14,15). Compared to animals that are exposed to either variable alone, the simultaneous imposition of both variables causes profound weight loss. As body weight progressively declines, running progressively increases. We argued the syndrome models two features of anorexia nervosa: hyperactivity and freely induced weight loss (16). Others argued that is also associated with an "activity anorexia"(11). However, the reduction in food intake is at least partly experimenter induced and animals exposed to the syndrome eat the same amount as animals comparably weight-reduced by simple food restriction (16). On the basis of these considerations, we argued that the term "anorexia" should not be applied and proposed that the syndrome be called an exercise-stress syndrome (16).
Yet other data we collected demonstrated that social isolation from weaning until adulthood increases vulnerability to the syndrome (17); that there are changes in insulin-like growth factor II gene expression (18); that chronic paraventricular hypothalamic alpha-2 adrenergic stimulation increases vulnerability to the syndrome (19); that water deprivation combined with free access to running wheels can produce a similar hyperactivity and weight-loss phenomenon (20); and that so-called glucoprivic stimulation paradoxically reduces appetite in animals subjected to the syndrome as it does in anorexics (16). Other data we collected suggest that, while beta-endorphin and dynorphin changes occur (21), they are not critically involved in the syndrome (see 13). Finally, we generated data several years ago implicating a deficiency in serotonin in the syndrome (22,23,24). Other investigators have made similar conclusions (25,26). The implication that a deficiency in brain serotonin is causally related to anorexia nervosa is paradoxical if the central substrate for the disorder is viewed at the level of the hypothalamus, where the acute administration of serotonin drugs suppresses appetite. However, there is evidence for serotonin abnormalities above the level of the hypothalamus in anorexia nervosa (27). Hence, the eating disorder is itself more than an eating disorder.
From this perspective, the central substrate for anorexia nervosa may importantly relate to the substrate for obsessive-compulsive disorder (OCD) (28). Anorexia nervosa has a variety of similarities with OCD and some authors describe it as an OCD spectrum disorder (29). Others argue that physical activity, starvation, and obsessive compulsiveness are intimately related (9). This argument has clear implications not only for anorexia nervosa but also for the female athlete triad. Serotonin reuptake inhibitors (SRIs) benefit OCD but not other antidepressant drugs (30). This raises the possibility that anorexia nervosa may also be successfully treated with SRIs. Beneficial effects have been reported in some (28) but not all (31) studies. More research is clearly needed on the interrelationship between OCD and anorexia nervosa.
One model well suited for this research is the exercise-stress syndrome. Not only is it a popular model of anorexia nervosa, it is also a model of OCD. This is because the hyperactivity can be attenuated by the selective SRI, fluoxetine, but not by a non-selective tricyclic antidepressant (26). Compulsive exercise is related to both anorexia nervosa (32) and the female athlete triad. Does the exercise-stress syndrome model other components of the triad?
It is well established that the exercise-stress syndrome models two components of the triad: disordered energy balance (33) and anestrous (34). However, to our knowledge, there are no reports demonstrating that the syndrome changes bone homeostasis. The reason for this, however, is that this possibility has not been heretofore considered. There is, however, an excellent reason to consider this proposal. It is well established that the syndrome activates the hypothalamo-pituitary-adrenal axis (HPA) (35). Importantly, the glucocorticoids are the most common cause of osteoporosis that is not menopause or age related (36).
A variety of animal models for anorexia nervosa have been proposed. These include transgenic mice over expressing corticotropin-releasing factor (37); the thin-sow syndrome in pigs (38); the anorexia produced by low-protein diets (39); strain differences in the ingestive effects of morphine in mice (40); restraint-stress anorexia (41); the spontaneous anorexias associated with hibernation (see 14); neurochemical depletion of the noradrenergic innervation of the paraventricular hypothalamic nucleus (see 42); and various contingent-exercised or forced-exercised models that lack either face or construct validity (see 14). However, there are relatively few model systems as pertinent to the female athlete triad as the exercise-stress syndrome. It has face, construct and criterion validity as an animal model of anorexia nervosa (14). This presentation concludes that it also a valid animal model of the female athlete triad. Consequently, the model is positioned to promote research on the psychoneuroendocrinology and psychoneuro-osteology of both anorexia nervosa and the female athlete triad.
1. Hill JO and Peters JC. Environmental contributions to the obesity epidemic. Science 1998 280:1371-1374.
2. Sohal RS and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996 273:59-63.
3. Holloszy JO. Longevity of exercising male rats: effect of an antioxidant supplement diet. Mech Aging Dev 1998 100:211-219.
4. Rosenberg IH. Let's get physical. Ann Intern Med 1998 129:133-134.
5. Bergh C and Sodersten P. Anorexia nervosa: rediscovery of a disorder. Lancet 1998 351:1427-1429.
6. Otis CL, Drinkwater B, Johnson M, Loucks A, Wilmore J. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 1997 29:I-IX.
7. Wilmore JH. Eating and weight disorders in the female athlete. Int J Sport Nutr 1991 1:104-117.
8. Walsh BT and Devlin MJ. Eating disorders: progress and problems. Science 1998 280:1387-1390.
9. Davis C, Kennedy SH, Ravelski E, Dionne M. The role of physical activity in the development and maintenance of eating disorders. Psychol Med 1994 24:957-967.
10. Kron L, Katz JL, Gorzynski G, Weiner H. Hyperactivity in anorexia nervosa: a fundamental feature. Compr Psychiatry 1978 19:433-440.
11. Epling WF and Pierce WD. An overview of activity anorexia. In WF Epling and WD Pierce (Eds.), Activity Anorexia. Theory, Research, and Treatment. Mahwah, NJ: Lawrence Erlbaun Assoc., 1996, pp 3-12.
12. Garfinkel PE and Garner DM. Anorexia Nervosa: A Multidimensional Perspective. New York: Brunner Mazel, 1982.
13. Aravich PF. Adverse effects of exercise stress and restricted feeding in the rat: theoretical and neurobiological considerations. In WF Epling and WD Pierce (Eds.), Activity Anorexia. Theory, Research, and Treatment. Mahwah, NJ: Lawrence Erlbaun Assoc., 1996, pp 81-97.
14. Rieg TS. Validity criteria for animal models of anorexia nervosa involving activity anorexia. In WF Epling and WD Pierce (Eds.), Activity Anorexia. Theory, Research, and Treatment. Mahwah, NJ: Lawrence Erlbaun Assoc., 1996, pp 13-21.
15. Doerries LE. Gender differences in activity anorexia: predictable, paradoxical, or enigmatic. In WF Epling and WD Pierce (Eds.), Activity Anorexia. Theory, Research, and Treatment. Mahwah, NJ: Lawrence Erlbaun Assoc., 1996, pp 69-77.
16. Aravich PF, Stanley EZ, Doerries LE. Exercise and food-restricted rats produces 2DG feeding and metabolic abnormalities similar to anorexia nervosa. Physiol Behav 1995 57:147-153
17. Ness JW, Marshall TR, Aravich PF. Effects of rearing condition on restricted feeding and activity induced weight loss. Dev Psychobiol 1995 28:165-173.
18. Lauterio TJ, Rieg TS, Ahmed I, Aravich PF. Fluoxetine induced insulin-like growth factor II (IGF-II) changes in hypothalami of normal, exercised and food restricted rats. Regl Pept 1993 48:21-28.
19. Rieg TS, Aravich PF. Paraventricular hypothalamic clonidine increases rather than decreases susceptibility to activity-based anorexia. Behav Neurosci 1992 106:1015-1022.
20. Rieg TS, Doerries LE, O'Shea JG, Aravich PF. Water deprivation produces an exercise-induced weight loss phenomenon in the rat. Physiol Behav 1993 53:607-610.
21. Aravich PF, Rieg TS, Lauterio TJ, Doerries LE. beta-Endorphin and dynorphin abnormalities in rats subjected to exercise and restricted feeding: relationship to anorexia nervosa. Brain Res 1993 622:1-8
22. Aravich PF, Rieg TS, Ahmed I, Lauterio TJ. Fluoxetine induces vasopressin and oxytocin abnormalities in food restricted rats given voluntary exercise: relationship to anorexia nervosa. Brain Res 1993 612:180-189.
23. Rieg TS, Maestrello AM, Aravich PF. Weight cycling alters the effects of D-fenfluramine on susceptibility to activity-based anorexia. Am J Clin Nutr 1994 60:494-500
24. Aravich PF, Doerries LE, Rieg TS. Exercise induced weight loss in the rat and anorexia nervosa. Appetite 1994 23:195.
25. Altemus M, Glowa JR, and Murphy DL. Attenuation of food-restriction-induced running by chronic fluoxetine treatment. Psychopharmacol Bull 1993 29:397-400.
26. Altemus M, Glowa JR, Galliven E, Leong YM, Murphy DL. Effects of serotonergic agents on food-restriction-induced hyperactivity. Pharmacol Biochem Behav 1996 53:123-131.
27. Brewerton TD, Jimerson DC. Studies of serotonin function in anorexia nervosa. Psychiatry Res 1996 62:31-42.
28. Hsu LKG, Kaye W, Welzin T. Are the eating disorders related to obsessive compulsive disorder? Int J Eat Disord 1993 14:305-318.
29. McElroy SL, Phillips KA, Keck PE Jr. Obsessive compulsive spectrum disorder. J Clin Psychiatry 1994 55:33-51
30. Blier P, de Montigny C. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Biol Psychiatry 1998 44:313-323.
31. Attia E,. Haiman C, Walsh BT, Flater SR. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry 1998 155:548-551.
32. Brewerton TD, Stellefson EJ, Hibbs N, Hodges EL, Cochrane CE. Comparison of eating disorder patients with and without compulsive exercising. Int J Eat Disord 1995 17:413-416.
33. Spear NE, Hill WF. Methodological note: excessive weight loss in rats living in activity wheels. Psychol Rep 1962 11:437-438.
34. Watanabe K, Hara C, Ogawa N. Feeding conditions and estrous cycle of female rats under the activity-stress procedure from aspects of anorexia nervosa. Physiol Behav 1992 51:827-832.
35. Burden VR, White BD, Dean RG, Martin RJ. Activity of the hypothalamo-pituitary-adrenal axis is elevated in rats with activity-based anorexia. J Nutr 1993 123:1217-1225.
36. Gennari C, Martini G, Nuti R. Secondary osteoporosis. Aging (Milano) 1998 10:214-224.
37. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 1994 14:2579-2584.
38. Treasure JL and Owen JB. Intriguing links between animal behavior and anorexia nervosa. Int J Eat Disord 1997 21:307-311.
39. Mercer LP, Kelley DS, Haq A, and Humphries LL. Dietary induced anorexia: a review of involvement of the histaminergic system. J Am Coll Nutr 1996 15:223-230.
40. Marrazzi MA, McQuarters A, Barnes C, Lawhorn J, D'Amico-Rasmussen Q. Male/female comparison of morphine effect on food intake---relation to anorexia nervosa. Pharmacol Biochem Behav 1996 53:433-435.
41. Grignaschi G, Mantelli B, Samanin R. The hypophagic effect of restraint stress in rats can be mediated by 5-HT2 receptors in the paraventricular nucleus of the hypothalamus. Neurosci Lett 1993 152:103-106.
42. Smith GP. Animal models of human eating disorders. Ann NY Acad Sci 1989 575:63-72.
| Discussion Board | Previous Page | Your Poster Session |
|Aravich, P.; Rieg, T.; Doerries, L.; (1998). The Female Athlete Triad and Anorexia Nervosa: Animal Modeling. Presented at INABIS '98 - 5th Internet World Congress on Biomedical Sciences at McMaster University, Canada, Dec 7-16th. Available at URL http://www.mcmaster.ca/inabis98/medicine/aravich0470/index.html|
|© 1998 Author(s) Hold Copyright|